Ross C, Ward ZJ, Gomber A, et al. The prevalence of islet autoantibodies in children and adolescents with type 1 diabetes mellitus: a global scoping review. Front Endocrinol. 2022;13:815703.

Article  Google Scholar 

Lampasona V, Schlosser M, Mueller PW, et al. Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8. Clin Chem. 2011;57:1693–702.

Article  CAS  PubMed  Google Scholar 

Törn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ; Participating Laboratories. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia. 2008;51:846–52.

Bingley PJ. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab. 2010;95:25–33.

Article  CAS  PubMed  Google Scholar 

Merjaneh L, Dolan LM, Suerken CK, et al. A longitudinal assessment of diabetes autoantibodies in the SEARCH for diabetes in youth study. Pediatr Diabetes. 2022;23:1027–37.

Article  CAS  PubMed  Google Scholar 

Singh AK, Bhatia E, Dabadghao P, Bhatia V, Gellert SA, Colman P. Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young North Indians. Diabet Med. 2000;17:275–80.

Article  CAS  PubMed  Google Scholar 

Fida S, Myers M, Mackay IR, et al. Antibodies to diabetes-associated autoantigens in Indian patients with type 1 diabetes: prevalence of anti-ICA512/IA2 and anti-SOX13. Diabetes Res Clin Pract. 2001;52:205–11.

Article  CAS  PubMed  Google Scholar 

Goswami R, Kochupillai N, Gupta N, Kukreja A, Lan M, Maclaren NK. Islet cell autoimmunity in youth onset diabetes mellitus in Northern India. Diabetes Res Clin Pract. 2001;53:47–54.

Article  CAS  PubMed  Google Scholar 

Tandon N, Shtauvere-Brameus A, Hagopian WA, Sanjeevi CB. Prevalence of ICA-12 and other autoantibodies in North Indian patients with early-onset diabetes. Ann N Y Acad Sci. 2002;958:214–7.

Article  CAS  PubMed  Google Scholar 

Ahmad J, Siddiqui MdS, Ahmed F, Farooqui KJ, Siddiqui MdA, Khan AR. Prevalence of autoantibodies and risk estimation of development of youth onset type 1 diabetes in Northern India. Diabetes Metab Syndr Clin Res Rev. 2008;2:59–64.

Balasubramanian K, Dabadghao P, Bhatia V, et al. High frequency of type 1B (idiopathic) diabetes in North Indian children with recent-onset diabetes. Diabetes Care. 2003;26:2697.

Article  PubMed  Google Scholar 

Vipin VP, Zaidi G, Watson K, et al. High prevalence of idiopathic (islet antibody-negative) type 1 diabetes among Indian children and adolescents. Pediatr Diabetes. 2021;22:47–51.

Article  CAS  PubMed  Google Scholar 

Kolb H, Dannehl K, Grüneklee D, et al. Prospective analysis of islet cell antibodies in children with type 1 (insulin-dependent) diabetes. Diabetologia. 1988;31:189–94.

Article  CAS  PubMed  Google Scholar 

Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M. Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children. Diabetologia. 1998;41:1293–7.

Article  CAS  PubMed  Google Scholar 

Yokota I, Matsuda J, Naito E, Ito M, Shima K, Kuroda Y. Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM. Diabetes Care. 1998;21:49–52.

Article  CAS  PubMed  Google Scholar 

Wenzlau JM, Walter M, Gardner TJ, et al. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab. 2010;95:4712–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chuzho N, Kumar N, Mishra N, et al. Differential HLA association of GAD65 and IA2 autoantibodies in north Indian type 1 diabetes patients. J Diabetes Res. 2021;2021:4012893.

Article  PubMed  PubMed Central  Google Scholar 

Oram RA, Jones AG, Besser RE, et al. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia. 2014;57:187–91.

Article  CAS  PubMed  Google Scholar 

Marzinotto I, Pittman DL, Williams AJK, et al; Participating Laboratories. Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops. Diabetologia. 2023;66:897–912.

Andersson C, Vaziri-Sani F, Delli A, et al; BDD Study Group. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Pediatr Diabetes. 2013;14:97–105.

Article  CAS  PubMed  Google Scholar 

Juusola M, Parkkola A, Härkönen T, et al; Childhood Diabetes in Finland Study Group. Positivity for zinc transporter 8 autoantibodies at diagnosis is subsequently associated with reduced β-cell function and higher exogenous insulin requirement in children and adolescents with type 1 diabetes. Diabetes Care. 2016;39:118–21.

Article  CAS  PubMed  Google Scholar 

Kawasaki E. Anti-islet autoantibodies in type 1 diabetes. Int J Mol Sci. 2023;24:10012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wenzlau JM, Frisch LM, Hutton JC, Fain PR, Davidson HW. Changes in zinc transporter 8 autoantibodies following type 1 diabetes onset: the type 1 diabetes genetics consortium autoantibody workshop. Diabetes Care. 2015;38:S14–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanga U, Vaidyanathan B, Jaini R, Menon PS, Mehra NK. HLA haplotypes associated with type 1 diabetes mellitus in North Indian children. Hum Immunol. 2004;65:47–53.

Article  CAS  PubMed  Google Scholar 

Singh S, Usha, Singh G, Agrawal NK, Singh RG, Kumar SB. Prevalence of autoantibodies and HLA DR, DQ in type 1 diabetes mellitus. J Clin Diagn Res. 2016;10:EC09–13.

CAS  PubMed  PubMed Central  Google Scholar 

Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Persson B, Lernmark A. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset. J Autoimmun. 2002;18:49–53.

Article  PubMed  Google Scholar 

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. J Clin Endocrinol Metab. 1987;65:30–6.

Mortensen HB, Swift PG, Holl RW, et al; Hvidoere Study Group on Childhood Diabetes. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatr Diabetes. 2010;11:218–26.

Article  CAS  PubMed  Google Scholar 

Hameed S, Ellard S, Woodhead HJ, et al. Persistently autoantibody negative (PAN) type 1 diabetes mellitus in children. Pediatr Diabetes. 2011;12:142–9.

Article  CAS  PubMed  Google Scholar 

Wang J, Miao D, Babu S, et al. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab. 2007;92:88–92.

Article  CAS  PubMed  Google Scholar